{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T16:34:08Z","timestamp":1788194048149,"version":"build-2803163510"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s12035-025-04821-9","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T21:56:41Z","timestamp":1742421401000},"page":"9449-9468","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Use of Drugs Affecting GABAA Receptors and the Risk of Developing Alzheimer\u2019s Disease and Dementia: a Meta-Analysis and Literature Review"],"prefix":"10.1007","volume":"62","author":[{"given":"Kimia","family":"Vakili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mobina","family":"Fathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasoul","family":"Ebrahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarina","family":"Ahmadian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maral","family":"Moafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Javad","family":"Ebrahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Tafazolimoghadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Davoodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirreza","family":"Eghbaldoost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimia","family":"Eyvani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani","family":"Ghayyem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehraeen","family":"Jashni Pour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3846-5466","authenticated-orcid":false,"given":"Mohammadreza","family":"Kosari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepideh","family":"Niknejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Sanaye Abbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ameneh","family":"Zarebidoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7982-4437","authenticated-orcid":false,"given":"Melissa","family":"Andrew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7514-8972","authenticated-orcid":false,"given":"Shanna","family":"Trenaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehra","family":"Batool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Sayehmiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaveh","family":"Ebrahimzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,20]]},"reference":[{"issue":"6","key":"4821_CR1","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1192\/bjp.164.6.796","volume":"164","author":"J Park","year":"1994","unstructured":"Park J, Ko HJ, Park YN, Chul-Ho J (1994) Dementia among the elderly in a rural Korean community. Br J Psychiatry 164(6):796\u2013801","journal-title":"Br J Psychiatry"},{"key":"4821_CR2","unstructured":"Prince M et al (2016) World Alzheimer report 2016: improving healthcare for people living with dementia: coverage, quality and costs now and in the future.\u00a0https:\/\/www.alzint.org\/resource\/world-alzheimer-report-2016\/. Accessed 25 Sept 2024"},{"issue":"2","key":"4821_CR3","first-page":"e47","volume":"10","author":"Association A.s.","year":"2014","unstructured":"Association A.s. (2014) Alzheimer\u2019s disease facts and figures. Alzheimers Dement 10(2):e47\u2013e92","journal-title":"Alzheimers Dement"},{"issue":"1","key":"4821_CR4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"MA DeTure","year":"2019","unstructured":"DeTure MA, Dickson DW (2019) The neuropathological diagnosis of Alzheimer\u2019s disease. Mol Neurodegener 14(1):32","journal-title":"Mol Neurodegener"},{"issue":"3","key":"4821_CR5","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","volume":"120","author":"GG Glenner","year":"1984","unstructured":"Glenner GG, Wong CW (1984) Alzheimer\u2019s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120(3):885\u2013890","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"4821_CR6","first-page":"89","volume":"17","author":"JP Brion","year":"1985","unstructured":"Brion JP, Couck A, Passareiro E, Flament-Durand J (1985) Neurofibrillary tangles of Alzheimer\u2019s disease: an immunohistochemical study. J Submicrosc Cytol 17(1):89\u201396","journal-title":"J Submicrosc Cytol"},{"issue":"8517","key":"4821_CR7","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(86)92212-9","volume":"328","author":"N Pollock","year":"1986","unstructured":"Pollock N et al (1986) Filamentous aggregates in Pick\u2019s disease, progressive supranuclear palsy, and Alzheimer\u2019s disease share antigenic determinants with microtubule-associated protein, tau. The Lancet 328(8517):1211","journal-title":"The Lancet"},{"key":"4821_CR8","doi-asserted-by":"crossref","unstructured":"Wu J et al (2011) Arc\/Arg3. 1 regulates an endosomal pathway essential for activity-dependent \u03b2-amyloid generation. Cell 147(3):615\u2013628","DOI":"10.1016\/j.cell.2011.09.036"},{"issue":"10","key":"4821_CR9","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jalz.2016.03.018","volume":"12","author":"DM Holtzman","year":"2016","unstructured":"Holtzman DM et al (2016) Tau: from research to clinical development. Alzheimers Dement 12(10):1033\u20131039","journal-title":"Alzheimers Dement"},{"issue":"4","key":"4821_CR10","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1136\/jnnp.67.4.558","volume":"67","author":"T Babic","year":"1999","unstructured":"Babic T (1999) The cholinergic hypothesis of Alzheimer\u2019s disease: a review of progress. J Neurol Neurosurg Psychiatry 67(4):558\u2013558","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"4821_CR11","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/0306-4522(83)90108-2","volume":"10","author":"M Mesulam","year":"1983","unstructured":"Mesulam M, Mufson E, Wainer B, Levey A (1983) Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1\u2013Ch6). Neuroscience 10(4):1185\u20131201","journal-title":"Neuroscience"},{"issue":"2","key":"4821_CR12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/cne.902390210","volume":"239","author":"M Frotscher","year":"1985","unstructured":"Frotscher M, L\u00e9r\u00e1nth C (1985) Cholinergic innervation of the rat hippocampus as revealed by choline acetyltransferase immunocytochemistry: a combined light and electron microscopic study. Journal of Comparative Neurology 239(2):237\u2013246","journal-title":"Journal of Comparative Neurology"},{"issue":"25","key":"4821_CR13","doi-asserted-by":"crossref","first-page":"10071","DOI":"10.1073\/pnas.1204606109","volume":"109","author":"A Limon","year":"2012","unstructured":"Limon A, Reyes-Ruiz JM, Miledi R (2012) Loss of functional GABAA receptors in the Alzheimer diseased brain. Proc Natl Acad Sci 109(25):10071\u201310076","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"4821_CR14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3233\/JAD-2011-110830","volume":"29","author":"S Krantic","year":"2012","unstructured":"Krantic S et al (2012) Hippocampal GABAergic neurons are susceptible to amyloid-\u03b2 toxicity in vitro and are decreased in number in the Alzheimer\u2019s disease TgCRND8 mouse model. J Alzheimers Dis 29(2):293\u2013308","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"4821_CR15","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/070674370404900705","volume":"49","author":"KL Lanct\u00f4t","year":"2004","unstructured":"Lanct\u00f4t KL et al (2004) GABAergic function in Alzheimer\u2019s disease: evidence for dysfunction and potential as a therapeutic target for the treatment of behavioural and psychological symptoms of dementia. The Canadian Journal of Psychiatry 49(7):439\u2013453","journal-title":"The Canadian Journal of Psychiatry"},{"issue":"4","key":"4821_CR16","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.neures.2005.04.008","volume":"52","author":"BY Lee","year":"2005","unstructured":"Lee BY, Ban JY, Seong YH (2005) Chronic stimulation of GABAA receptor with muscimol reduces amyloid \u03b2 protein (25\u201335)-induced neurotoxicity in cultured rat cortical cells. Neurosci Res 52(4):347\u2013356","journal-title":"Neurosci Res"},{"issue":"7","key":"4821_CR17","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1179\/016164104225014148","volume":"26","author":"X Lin","year":"2004","unstructured":"Lin X, Jun-Tian Z (2004) Neuroprotection by D-securinine against neurotoxicity induced by beta-amyloid (25\u201335). Neurol Res 26(7):792\u2013796","journal-title":"Neurol Res"},{"issue":"3","key":"4821_CR18","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1096\/fj.03-0739com","volume":"18","author":"PR Louzada","year":"2004","unstructured":"Louzada PR et al (2004) Taurine prevents the neurotoxicity of \u03b2-amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer\u2019s disease and other neurological disorders. FASEB J 18(3):511\u2013518","journal-title":"FASEB J"},{"issue":"6","key":"4821_CR19","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/jnc.14345","volume":"146","author":"B Calvo-Flores Guzm\u00e1n","year":"2018","unstructured":"Calvo-Flores Guzm\u00e1n B et al (2018) The GABAergic system as a therapeutic target for Alzheimer\u2019s disease. J Neurochem 146(6):649\u2013669","journal-title":"J Neurochem"},{"issue":"2","key":"4821_CR20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2125.2006.02744.x","volume":"63","author":"KK Viktil","year":"2007","unstructured":"Viktil KK, Blix HS, Moger TA, Reikvam A (2007) Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol 63(2):187\u2013195","journal-title":"Br J Clin Pharmacol"},{"issue":"17","key":"4821_CR21","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1523\/JNEUROSCI.5663-11.2012","volume":"32","author":"MC Gielen","year":"2012","unstructured":"Gielen MC, Lumb MJ, Smart TG (2012) Benzodiazepines modulate GABAA receptors by regulating the preactivation step after GABA binding. J Neurosci 32(17):5707\u20135715","journal-title":"J Neurosci"},{"issue":"11","key":"4821_CR22","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1016\/j.clinthera.2016.09.010","volume":"38","author":"JL Schroeck","year":"2016","unstructured":"Schroeck JL et al (2016) Review of safety and efficacy of sleep medicines in older adults. Clin Ther 38(11):2340\u20132372","journal-title":"Clin Ther"},{"key":"4821_CR23","doi-asserted-by":"crossref","unstructured":"Schmitz A (2021) Benzodiazepines: the time for systematic change is now. Wiley Online Library, p 219\u2013221","DOI":"10.1111\/add.15095"},{"issue":"11","key":"4821_CR24","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1001\/jama.1996.03530350034031","volume":"275","author":"SK Inouye","year":"1996","unstructured":"Inouye SK, Charpentier PA (1996) Precipitating factors for delirium in hospitalized elderly persons: predictive model and interrelationship with baseline vulnerability. JAMA 275(11):852\u2013857","journal-title":"JAMA"},{"issue":"2","key":"4821_CR25","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3233\/JAD-151006","volume":"54","author":"W Gomm","year":"2016","unstructured":"Gomm W et al (2016) Regular benzodiazepine and Z-substance use and risk of dementia: an analysis of German claims data. J Alzheimers Dis 54(2):801\u2013808","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"4821_CR26","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jalz.2015.10.006","volume":"12","author":"D Shash","year":"2016","unstructured":"Shash D et al (2016) Benzodiazepine, psychotropic medication, and dementia: a population-based cohort study. Alzheimers Dement 12(5):604\u2013613","journal-title":"Alzheimers Dement"},{"issue":"10","key":"4821_CR27","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s40264-015-0319-3","volume":"38","author":"P Imfeld","year":"2015","unstructured":"Imfeld P, Bodmer M, Jick SS, Meier CR (2015) Benzodiazepine use and risk of developing alzheimer\u2019s disease or vascular dementia: a case\u2013control analysis. Drug Saf 38(10):909\u2013919","journal-title":"Drug Saf"},{"key":"4821_CR28","volume":"349","author":"SB De Gage","year":"2014","unstructured":"De Gage SB et al (2014) Benzodiazepine use and risk of Alzheimer\u2019s disease: case-control study. BMJ 349:g5205","journal-title":"BMJ"},{"issue":"5","key":"4821_CR29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127836","volume":"10","author":"G Zhong","year":"2015","unstructured":"Zhong G, Wang Y, Zhang Y, Zhao Y (2015) Association between benzodiazepine use and dementia: a meta-analysis. PLoS ONE 10(5):e0127836","journal-title":"PLoS ONE"},{"issue":"4","key":"4821_CR30","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2165\/00003495-200059040-00014","volume":"59","author":"KJ Holm","year":"2000","unstructured":"Holm KJ, Goa KL (2000) Zolpidem. Drugs 59(4):865\u2013889","journal-title":"Drugs"},{"issue":"11","key":"4821_CR31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112068","volume":"9","author":"T Berdyyeva","year":"2014","unstructured":"Berdyyeva T et al (2014) Zolpidem reduces hippocampal neuronal activity in freely behaving mice: a large scale calcium imaging study with miniaturized fluorescence microscope. PLoS ONE 9(11):e112068","journal-title":"PLoS ONE"},{"issue":"3","key":"4821_CR32","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1192\/bjp.bp.112.119610","volume":"204","author":"P-L Chen","year":"2014","unstructured":"Chen P-L et al (2014) Risk of dementia after anaesthesia and surgery. Br J Psychiatry 204(3):188\u2013193","journal-title":"Br J Psychiatry"},{"issue":"5","key":"4821_CR33","first-page":"988","volume":"104","author":"Z Xie","year":"2006","unstructured":"Xie Z et al (2006) The common inhalation anesthetic isoflurane induces apoptosis and increases amyloid \u03b2 protein levels. The Journal of the American Society of Anesthesiologists 104(5):988\u2013994","journal-title":"The Journal of the American Society of Anesthesiologists"},{"issue":"6","key":"4821_CR34","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ana.21548","volume":"64","author":"Z Xie","year":"2008","unstructured":"Xie Z et al (2008) The common inhalation anesthetic isoflurane induces caspase activation and increases amyloid \u03b2-protein level in vivo. Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society 64(6):618\u2013627","journal-title":"Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society"},{"issue":"3","key":"4821_CR35","first-page":"703","volume":"101","author":"RG Eckenhoff","year":"2004","unstructured":"Eckenhoff RG et al (2004) Inhaled anesthetic enhancement of amyloid-\u03b2 oligomerization and cytotoxicity. The Journal of the American Society of Anesthesiologists 101(3):703\u2013709","journal-title":"The Journal of the American Society of Anesthesiologists"},{"issue":"7","key":"4821_CR36","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.neurobiolaging.2007.02.009","volume":"29","author":"SL Bianchi","year":"2008","unstructured":"Bianchi SL et al (2008) Brain and behavior changes in 12-month-old Tg2576 and nontransgenic mice exposed to anesthetics. Neurobiol Aging 29(7):1002\u20131010","journal-title":"Neurobiol Aging"},{"issue":"8","key":"4821_CR37","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1096\/fj.08-122424","volume":"23","author":"E Planel","year":"2009","unstructured":"Planel E et al (2009) Acceleration and persistence of neurofibrillary pathology in a mouse model of tauopathy following anesthesia. FASEB J 23(8):2595\u20132604","journal-title":"FASEB J"},{"issue":"4","key":"4821_CR38","first-page":"727","volume":"115","author":"JX Tang","year":"2011","unstructured":"Tang JX et al (2011) Human Alzheimer and inflammation biomarkers after anesthesia and surgery. The Journal of the American Society of Anesthesiologists 115(4):727\u2013732","journal-title":"The Journal of the American Society of Anesthesiologists"},{"issue":"6","key":"4821_CR39","volume":"7","author":"Y Dong","year":"2012","unstructured":"Dong Y et al (2012) Anesthetic isoflurane increases phosphorylated tau levels mediated by caspase activation and A\u03b2 generation. PLoS ONE 7(6):e39386","journal-title":"PLoS ONE"},{"issue":"5","key":"4821_CR40","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1001\/archneurol.2009.48","volume":"66","author":"Y Dong","year":"2009","unstructured":"Dong Y et al (2009) The common inhalational anesthetic sevoflurane induces apoptosis and increases \u03b2-amyloid protein levels. Arch Neurol 66(5):620\u2013631","journal-title":"Arch Neurol"},{"key":"4821_CR41","doi-asserted-by":"crossref","unstructured":"Tang JX et al (2011) Anesthesia in presymptomatic Alzheimer\u2019s disease: a study using the triple-transgenic mouse model. Alzheimers Dement\u00a07(5):521\u2013531. e1","DOI":"10.1016\/j.jalz.2010.10.003"},{"issue":"4","key":"4821_CR42","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/ijnp\/pyab073","volume":"25","author":"F Torres-Bondia","year":"2022","unstructured":"Torres-Bondia F et al (2022) Benzodiazepine and Z-drug use and the risk of developing dementia. Int J Neuropsychopharmacol 25(4):261\u2013268","journal-title":"Int J Neuropsychopharmacol"},{"issue":"1","key":"4821_CR43","volume":"8","author":"G Joyce","year":"2022","unstructured":"Joyce G et al (2022) Benzodiazepine use and the risk of dementia. Alzheimers Dement (N Y) 8(1):e12309","journal-title":"Alzheimers Dement (N Y)"},{"issue":"1","key":"4821_CR44","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/acps.13380","volume":"145","author":"M Tournier","year":"2022","unstructured":"Tournier M et al (2022) The risk of dementia in patients using psychotropic drugs: antidepressants, mood stabilizers or antipsychotics. Acta Psychiatr Scand 145(1):56\u201366","journal-title":"Acta Psychiatr Scand"},{"issue":"5","key":"4821_CR45","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/psyg.12239","volume":"17","author":"T-T Chan","year":"2017","unstructured":"Chan T-T et al (2017) Association between high cumulative dose of benzodiazepine in Chinese patients and risk of dementia: a preliminary retrospective case-control study. Psychogeriatrics 17(5):310\u2013316","journal-title":"Psychogeriatrics"},{"issue":"17","key":"4821_CR46","volume":"94","author":"HI Shih","year":"2015","unstructured":"Shih HI et al (2015) An increased risk of reversible dementia may occur after zolpidem derivative use in the elderly population: a population-based case-control study. Medicine (Baltimore) 94(17):e809","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"4821_CR47","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1111\/jgs.15018","volume":"65","author":"HT Cheng","year":"2017","unstructured":"Cheng HT et al (2017) The association between the use of zolpidem and the risk of Alzheimer\u2019s disease among older people. J Am Geriatr Soc 65(11):2488\u20132495","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"4821_CR48","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/0898264318795567","volume":"31","author":"SL Burke","year":"2019","unstructured":"Burke SL et al (2019) Treatment of sleep disturbance may reduce the risk of future probable Alzheimer\u2019s disease. J Aging Health 31(2):322\u2013342","journal-title":"J Aging Health"},{"issue":"9","key":"4821_CR49","volume":"13","author":"J Lee","year":"2018","unstructured":"Lee J et al (2018) Use of sedative-hypnotics and the risk of Alzheimer\u2019s dementia: a retrospective cohort study. PLoS ONE 13(9):e0204413","journal-title":"PLoS ONE"},{"key":"4821_CR50","doi-asserted-by":"crossref","first-page":"g5205","DOI":"10.1136\/bmj.g5205","volume":"349","author":"S Billioti de Gage","year":"2014","unstructured":"Billioti de Gage S et al (2014) Benzodiazepine use and risk of Alzheimer\u2019s disease: case-control study. BMJ 349:g5205","journal-title":"BMJ"},{"key":"4821_CR51","volume":"352","author":"SL Gray","year":"2016","unstructured":"Gray SL et al (2016) Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study. BMJ 352:i90","journal-title":"BMJ"},{"issue":"3","key":"4821_CR52","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/1060028019882037","volume":"54","author":"M Nafti","year":"2020","unstructured":"Nafti M et al (2020) Is benzodiazepine use associated with the risk of dementia and cognitive impairment-not dementia in older persons? The Canadian study of health and aging. Ann Pharmacother 54(3):219\u2013225","journal-title":"Ann Pharmacother"},{"issue":"2","key":"4821_CR53","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/acps.12909","volume":"138","author":"V Tapiainen","year":"2018","unstructured":"Tapiainen V et al (2018) The risk of Alzheimer\u2019s disease associated with benzodiazepines and related drugs: a nested case-control study. Acta Psychiatr Scand 138(2):91\u2013100","journal-title":"Acta Psychiatr Scand"},{"issue":"4","key":"4821_CR54","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.3233\/JAD-201319","volume":"81","author":"W Jeong","year":"2021","unstructured":"Jeong W et al (2021) Association between the use of hypnotics and the risk of Alzheimer\u2019s disease. J Alzheimers Dis 81(4):1381\u20131389","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"4821_CR55","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s40263-016-0404-x","volume":"31","author":"FA Bi\u00e9try","year":"2017","unstructured":"Bi\u00e9try FA et al (2017) Benzodiazepine use and risk of developing Alzheimer\u2019s disease: a case-control study based on Swiss claims data. CNS Drugs 31(3):245\u2013251","journal-title":"CNS Drugs"},{"issue":"1","key":"4821_CR56","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s12877-019-1280-2","volume":"19","author":"CM Grossi","year":"2019","unstructured":"Grossi CM et al (2019) Anticholinergic and benzodiazepine medication use and risk of incident dementia: a UK cohort study. BMC Geriatr 19(1):276","journal-title":"BMC Geriatr"},{"issue":"3","key":"4821_CR57","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.medcli.2020.02.006","volume":"156","author":"P Aldaz","year":"2021","unstructured":"Aldaz P et al (2021) Association between benzodiazepine use and development of dementia. Med Clin (Barc) 156(3):107\u2013111","journal-title":"Med Clin (Barc)"},{"issue":"3","key":"4821_CR58","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3233\/JAD-191199","volume":"74","author":"K Richardson","year":"2020","unstructured":"Richardson K et al (2020) Neuropathological correlates of cumulative benzodiazepine and anticholinergic drug use. J Alzheimers Dis 74(3):999\u20131009","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"4821_CR59","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000295114","volume":"29","author":"C Zuo","year":"2010","unstructured":"Zuo C, Zuo Z (2010) Spine Surgery under general anesthesia may not increase the risk of Alzheimer\u2019s disease. Dement Geriatr Cogn Disord 29(3):233\u2013239","journal-title":"Dement Geriatr Cogn Disord"},{"key":"4821_CR60","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.brainres.2018.11.042","volume":"1707","author":"EA Giovannetti","year":"2019","unstructured":"Giovannetti EA, Fuhrmann M (2019) Unsupervised excitation: GABAergic dysfunctions in Alzheimer\u2019s disease. Brain Res 1707:216\u2013226","journal-title":"Brain Res"},{"issue":"34","key":"4821_CR61","doi-asserted-by":"crossref","first-page":"4960","DOI":"10.2174\/1381612821666150914121149","volume":"21","author":"M Solas","year":"2015","unstructured":"Solas M, Puerta E, Ramirez MJ (2015) Treatment options in Alzheimer s disease: the GABA story. Curr Pharm Des 21(34):4960\u20134971","journal-title":"Curr Pharm Des"},{"issue":"6","key":"4821_CR62","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1007\/s11064-021-03289-y","volume":"46","author":"P Babaei","year":"2021","unstructured":"Babaei P, Eyvani K, Kouhestani S (2021) Sex-independent cognition improvement in response to kaempferol in the model of sporadic Alzheimer\u2019s disease. Neurochem Res 46(6):1480\u20131486","journal-title":"Neurochem Res"},{"issue":"2","key":"4821_CR63","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pharep.2014.09.004","volume":"67","author":"A Kumar","year":"2015","unstructured":"Kumar A, Singh A (2015) A review on Alzheimer\u2019s disease pathophysiology and its management: an update. Pharmacol Rep 67(2):195\u2013203","journal-title":"Pharmacol Rep"},{"issue":"1","key":"4821_CR64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12877-019-1280-2","volume":"19","author":"CM Grossi","year":"2019","unstructured":"Grossi CM et al (2019) Anticholinergic and benzodiazepine medication use and risk of incident dementia: a UK cohort study. BMC Geriatr 19(1):1\u201310","journal-title":"BMC Geriatr"},{"issue":"3","key":"4821_CR65","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.cell.2012.02.046","volume":"149","author":"L Verret","year":"2012","unstructured":"Verret L et al (2012) Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model. Cell 149(3):708\u2013721","journal-title":"Cell"},{"issue":"2","key":"4821_CR66","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/mp.2008.66","volume":"15","author":"N Craddock","year":"2010","unstructured":"Craddock N et al (2010) Strong genetic evidence for a selective influence of GABAA receptors on a component of the bipolar disorder phenotype. Mol Psychiatry 15(2):146\u2013153","journal-title":"Mol Psychiatry"},{"issue":"1","key":"4821_CR67","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.neuron.2017.11.028","volume":"97","author":"S Frere","year":"2018","unstructured":"Frere S, Slutsky I (2018) Alzheimer\u2019s disease: from firing instability to homeostasis network collapse. Neuron 97(1):32\u201358","journal-title":"Neuron"},{"issue":"6453","key":"4821_CR68","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1126\/science.aay5188","volume":"365","author":"DJ Selkoe","year":"2019","unstructured":"Selkoe DJ (2019) Early network dysfunction in Alzheimer\u2019s disease. Science 365(6453):540\u2013541","journal-title":"Science"},{"key":"4821_CR69","first-page":"31","volume":"8","author":"Y Li","year":"2016","unstructured":"Li Y et al (2016) Implications of GABAergic neurotransmission in Alzheimer\u2019s disease. Frontiers in aging neuroscience 8:31","journal-title":"Frontiers in aging neuroscience"},{"key":"4821_CR70","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s10072-013-1289-9","volume":"34","author":"MC Gueli","year":"2013","unstructured":"Gueli MC, Taibi G (2013) Alzheimer\u2019s disease: amino acid levels and brain metabolic status. Neurol Sci 34:1575\u20131579","journal-title":"Neurol Sci"},{"issue":"11","key":"4821_CR71","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/archneur.1982.00510230035010","volume":"39","author":"SR Bareggi","year":"1982","unstructured":"Bareggi SR et al (1982) Decreased CSF concentrations of homovanillic acid and \u03b3-aminobutyric acid in Alzheimer\u2019s disease: age-or disease-related modifications? Arch Neurol 39(11):709\u2013712","journal-title":"Arch Neurol"},{"issue":"1","key":"4821_CR72","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0304-3940(98)00698-3","volume":"255","author":"D Grouselle","year":"1998","unstructured":"Grouselle D et al (1998) Loss of somatostatin-like immunoreactivity in the frontal cortex of Alzheimer patients carrying the apolipoprotein epsilon 4 allele. Neurosci Lett 255(1):21\u201324","journal-title":"Neurosci Lett"},{"issue":"9","key":"4821_CR73","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/jnr.23244","volume":"91","author":"SQ Zhang","year":"2013","unstructured":"Zhang SQ et al (2013) Baicalein reduces \u03b2-amyloid and promotes nonamyloidogenic amyloid precursor protein processing in an Alzheimer\u2019s disease transgenic mouse model. J Neurosci Res 91(9):1239\u20131246","journal-title":"J Neurosci Res"},{"issue":"1","key":"4821_CR74","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s43141-021-00224-0","volume":"19","author":"A Ghit","year":"2021","unstructured":"Ghit A, Assal D, Al-Shami AS, Hussein DEE (2021) GABAA receptors: structure, function, pharmacology, and related disorders. Journal of Genetic Engineering and Biotechnology 19(1):123","journal-title":"Journal of Genetic Engineering and Biotechnology"},{"issue":"3","key":"4821_CR75","first-page":"107","volume":"156","author":"P Aldaz","year":"2021","unstructured":"Aldaz P et al (2021) Association between benzodiazepine use and development of dementia. Med Cl\u00edn (Engl Ed) 156(3):107\u2013111","journal-title":"Med Cl\u00edn (Engl Ed)"},{"issue":"17","key":"4821_CR76","doi-asserted-by":"crossref","first-page":"e809","DOI":"10.1097\/MD.0000000000000809","volume":"94","author":"H-I Shih","year":"2015","unstructured":"Shih H-I et al (2015) An increased risk of reversible dementia may occur after zolpidem derivative use in the elderly population: a population-based case-control study. Medicine 94(17):e809","journal-title":"Medicine"},{"issue":"9","key":"4821_CR77","volume":"13","author":"J Lee","year":"2018","unstructured":"Lee J et al (2018) Use of sedative-hypnotics and the risk of Alzheimer\u2019s dementia: a retrospective cohort study. PLoS ONE 13(9):e0204413","journal-title":"PLoS ONE"},{"issue":"4","key":"4821_CR78","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1111\/bcp.15113","volume":"88","author":"A AlDawsari","year":"2022","unstructured":"AlDawsari A et al (2022) Use of sedative-hypnotic medications and risk of dementia: a systematic review and meta-analysis. Br J Clin Pharmacol 88(4):1567\u20131589","journal-title":"Br J Clin Pharmacol"},{"issue":"3\u20134","key":"4821_CR79","first-page":"181","volume":"47","author":"MM Islam","year":"2017","unstructured":"Islam MM et al (2017) Benzodiazepine use and risk of dementia in the elderly population: a systematic review and meta-analysis. Neuroepidemiology 47(3\u20134):181\u2013191","journal-title":"Neuroepidemiology"},{"issue":"3","key":"4821_CR80","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s41593-022-01013-9","volume":"25","author":"Y Shi","year":"2022","unstructured":"Shi Y et al (2022) Long-term diazepam treatment enhances microglial spine engulfment and impairs cognitive performance via the mitochondrial 18 kDa translocator protein (TSPO). Nat Neurosci 25(3):317\u2013329","journal-title":"Nat Neurosci"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04821-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-04821-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04821-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T11:31:36Z","timestamp":1751369496000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-04821-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,20]]},"references-count":80,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["4821"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-04821-9","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,20]]},"assertion":[{"value":"5 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The current study was approved by the Ethics Committee of Shahid Beheshti University of Medical Sciences (ethical code: IR.SBMU.RETECH.REC.1400.3260).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}